Ann Hunter

6.9k citations

70 papers · 4.0k indexed · 2 hit papers · h-index 31

Hematology top 0.2%
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 10
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 5
Pharmacology top 1%
Oncology top 5%
Immunology top 5%
Molecular Biology
- Glycosylation and Glycoproteins Research 8
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 8
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 7
Spectroscopy
- Mass Spectrometry Techniques and Applications 6
- Analytical Chemistry and Chromatography 5

Co-authors: Nigel H. Russell Robert K. Hills Alan K. Burnett Donald Milligan David J. Harvey Jonathan Kell Raymond A. Dwek Keith Wheatley
Cited by: Hematology Genetics Pharmacology
Journals: Blood (11 papers)British Journal of Haematology (7 papers)Rapid Communications in Mass Spectrometry (5 papers)
Partner nations: United Kingdom United States Denmark

In The Last Decade

Ann Hunter

70 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Ann Hunter

Since Specialization

Citations

This map shows the geographic impact of Ann Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Hunter more than expected).

Fields of papers citing papers by Ann Hunter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Hunter. The network helps show where Ann Hunter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ann Hunter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Hunter Line = papers co-authored together Ann Hunter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The synthesis, structure and solution and gas phase properties of complexes of scandium and lanthanide triflates with the phosphine oxide ligands PhP(O)(C2H4P(O)Ph2)2 and P(O)(C2H4P(O)Ph2)3 Polyhedron ·Simon J. Coles,Ann Hunter,A. Yu. Anan’eva,Waqar Khan,Laura J. McCormick,Andrew W.G. Platt	2025	1
2	Use of QuEChERS as a manual and automated high-throughput protocol for investigating environmental matrices Chemosphere ·A. Ruth Godfrey,Volodymyr Solomiichuk,Anthony Gravell,Ann Hunter,Mark P. Barrow,Geertje van Keulen,Claire Desbrow,Helena Lindgren	2022	12
3	A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial Leukemia ·Alan K. Burnett,Robert K. Hills,Olav Wendelboe Nielsen,Sylvie Freeman,Arwa Ali,Paul Cahalin,Ann Hunter,Ian F. Thomas,Nigel H. Russell	2018	12
4	Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialbreakdown → The Lancet Oncology ·Alan K. Burnett,Nigel H. Russell,Robert K. Hills,David Bowen,Jonathan Kell,Steven Knapper,Yvonne G Morgan,Sílvia Casian,Angela Grech,Gail Jones,Asim Khwaja,Lone S. Friis,Mary Frances McMullin,Ann Hunter,Richard E. Clark,David Grimwade	2015	346
5	Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial Leukemia ·Alan K. Burnett,Robert K. Hills,David Grimwade,Jelena Jovanović,J Craig,M. F. McMullin,Jonathan Kell,Keith Wheatley,J. A. Liu Yin,Ann Hunter,Don Milligan,Nigel H. Russell	2012	53
6	Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation Haematologica ·Alicia Rovó,Mahmoud Aljurf,S Chiodi,S Spinelli,Nina Salooja,Gülsan Türköz Sucak,Ann Hunter,N. Macready,G. Socié,M. T. Van Lint,Jakob Passweg,Mutlu Arat,Manuela Badoglio,André Tichelli,(unknown)	2012	23
7	The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome Leukemia ·Alan K. Burnett,Robert K. Hills,Ann Hunter,D Milligan,Jonathan Kell,Keith Wheatley,J. A. Liu Yin,グェンカクフン,Paul Cahalin,J Craig,David Bowen,Nigel H. Russell	2011	35
8	The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study British Journal of Haematology ·Jennifer M. Bird,Sonja Wasner,Bhawna Sirohi,Jane F. Apperley,Ann Hunter,John A. Snowden,Premini Mahendra,Donald Milligan,Jenny Byrne,Timothy J. Littlewood,Chris Fegan,Grant McQuaker,Antonio Pagliuca,Peter Johnson,Amin Rahemtulla,Curly Morris,David I. Marks	2006	44
9	Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning – evidence for a superior outcome using melphalan combined with total body irradiation British Journal of Haematology ·Hannah Hunter,Karl S. Peggs,R Powles,Amin Rahemtulla,P Mahendra,Jamie Cavenagh,Tim Littlewood,Mike Potter,Ann Hunter,Antonio Pagliuca,C. D. Williams,Gordon Cook,K. Towlson,Matthew E. Barnhart,Nigel H. Russell	2005	32
10	Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect. UCL Discovery (University College London) ·K Peggs,V. V. Kvasnyts’kyy,ピヤトーンケウワッタナ,Premini Mahendra,D W Milligan,Shirani Koorosh,Ann Hunter,Ruth Pettengell,Hernan Sanhueza,G Hale,Herman Waldmann,Emma Morris,AH Goldstone,DC Linch,Stephen Mackinnon	2003	5
11	The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma British Journal of Haematology ·Bronwen E. Shaw,Karl S. Peggs,Jennifer M. Bird,Jamie Cavenagh,Ann Hunter,J. Alejandro Madrigal,Nigel H. Russell,Bhawna Sirohi,K. Towlson,Catherine Williams,David I. Marks	2003	19
12	Oxidation of Guanine Nucleosides to 4-Amidinocarbamoyl- 5-hydroxyimidazoles by Dimethyldioxirane Nucleosides Nucleotides & Nucleic Acids ·R. Jeremy H. Davies,И.А. Знаменская,Shiv Kumar,J Wojcik,S. Louise Cosby,John F. Malone,Derek R. Boyd,Narain D. Sharma,Ann Hunter,Bridget K. Stein	2003	1
13	Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL). UCL Discovery (University College London) ·Emma Morris,V. V. Kvasnyts’kyy,Charles Craddock,D Milligan,Hidenori ISHII,潘恩山,Steve Schey,O. Kauders,ピヤトーンケウワッタナ,T. Littlewood,Bernardo Medina,Ann Hunter,Hanan Abdo Salim,Panagiotis Kottaridis,K Peggs,DC Linch,Anthony P. Goldstone,Stephen Mackinnon	2002	2
14	A family of novel, acidic N‐glycans in Bowes melanoma tissue plasminogen activator have L2/HNK‐1‐bearing antennae, many with sulfation of the fucosylated chitobiose core European Journal of Biochemistry ·Susanne Zamze,David Wing,Mark R. Wormald,Ann Hunter,Raymond A. Dwek,David J. Harvey	2001	15
15	[Experiences with introduction of the UNICEF program "10 steps for successful breast feeding"]. PubMed ·Yosra Yusuf,Stjepan Jelušić,Diana Henriques Pinto,Ann Hunter	1998	1
16	Structural determination of N‐linked carbohydrates by matrix‐assisted laser desorption/ionization‐mass spectrometry following enzymatic release within sodium dodecyl sulphate‐polyacrylamide electrophoresis gels: Application to species‐specific glycosylation of α₁‐acid glycoprotein Electrophoresis ·Bernhard Küster,Ann Hunter,Susan F. Wheeler,Raymond A. Dwek,David J. Harvey	1998	47
17	Ex vivo neutrophil function in response to three different doses of glycosylated rHuG‐CSF (Lenograstim) British Journal of Haematology ·Julie Turzanski,S. P. M. Crouch,John Fletcher,Ann Hunter	1997	26
18	Control of Activity through Oxidative Modification at the Conserved Residue Cys66 of Aryl Sulfotransferase IV Journal of Biological Chemistry ·Aileen Marshall,John F. Darbyshire,Ann Hunter,Peter McPhie,William B. Jakoby	1997	33
19	Evaluation of glycosylation site heterogeneity and selective identification of glycopeptides in proteolytic digests of bovine α₁‐acid glycoprotein by mass spectrometry Rapid Communications in Mass Spectrometry ·Ann Hunter,David E. Games	1995	31
20	Proton‐transfer reactions of mass‐selected multiply charged ions Rapid Communications in Mass Spectrometry ·Ann Hunter,Joanne C. Severs,F.M. Harris,David E. Games	1994	25

About Ann Hunter

Ann Hunter is a scholar working on Hematology, Genetics and Transplantation, having authored 70 papers that have together received 4.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (10 papers), Glycosylation and Glycoproteins Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Mass Spectrometry Techniques and Applications (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Analytical Chemistry and Chromatography (5 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (432 citations) and Pharmacology (298 citations). Ann Hunter has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Nigel H. Russell, Robert K. Hills, Alan K. Burnett, Donald Milligan, David J. Harvey, Jonathan Kell, Raymond A. Dwek, Keith Wheatley, Anthony H. Goldstone and Susan F. Wheeler. Their work appears in journals such as Blood, British Journal of Haematology, Rapid Communications in Mass Spectrometry, Physiotherapy and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact